Schwerin / 9.2.2024 – Hoffrichter GmbH announces the successful certification of its “Ivory pro” respiratory therapy devices. Following the “LAVI 30” and “LAVI 40” ventilators, which were already approved in 2023, the six variants of the “Ivory pro” series received Chinese approval in January 2024.

The “Ivory pro” series represents the Chinese version of the international “TREND III” from Hoffrichter. The certification underlines the company’s positioning in the Chinese market for respiratory therapy and out-of-hospital ventilation technologies. In addition to these products, Hoffrichter has certificates for “TRENDvent”, “iCARAT et”, “Vital” and “Ivory”.

The company remains committed to providing high-quality and innovative medical technology solutions to meet the needs of the Chinese market. 95% of our high-quality medical products are exported around the world from our site in Schwerin.